Is cancer a good way to die? A population-based survey among middle-aged and older adults in the United Kingdom by Vrinten, C & Wardle, J
European Journal of Cancer 56 (2016) 172e178Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.ejcancer.comOriginal ResearchIs cancer a good way to die? A population-based survey
among middle-aged and older adults in the United
KingdomCharlotte Vrinten*, Jane Wardle 1Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, Gower





Public perceptions* Corresponding author:Health Behav
Street, London, WC1E 6BT, United K
E-mail address: c.vrinten@ucl.ac.uk
1 Deceased October 20th 2015.
http://dx.doi.org/10.1016/j.ejca.2015.12.0
0959-8049/ª 2016 The Authors. Publish
licenses/by/4.0/).Abstract Objectives: Despite improved outcomes, cancer remains widely feared, often
because of its association with a long and protracted death as opposed to the quick death that
people associate with that other common cause of adult mortality: heart disease. Former
editor-in-chief of the BMJ Richard Smith’s view that ‘cancer is the best way to die’ therefore
attracted much criticism. We examined middle-aged and older adults’ agreement with this
view and compared their attitudes towards dying from cancer versus heart disease in terms
of which was a good death.
Methods: This study was part of an online survey (February 2015) in a United Kingdom (UK)
population sample of 50- to 70-year olds (nZ 391), with sampling quotas for gender and ed-
ucation. Five characteristics of ‘a good death’ were selected from the end-of-life literature. Re-
spondents were asked to rate the importance of each characteristic for their own death to
ensure their relevance to a population sample and the likelihood of each for death from cancer
and heart disease. We also asked whether they agreed with Smith’s view.
Results: At least 95% of respondents considered the selected five characteristics important for
their own death. Death from cancer was rated as more likely to provide control over what hap-
pens (p < 0.001), control over pain and other symptoms (p < 0.01), time to settle affairs
(p < 0.001), and time to say goodbye to loved ones (p < 0.001) compared with death from
heart disease, but there were no differences in expectation of living independently until death
(p > 0.05). Almost half (40%) agreed that cancer is ‘the best way to die’, with no differences by
age (p Z 0.40), gender (p Z 0.85), or education (p Z 0.27).iour Research Centre, Department of Epidemiology and Public Health, University College London, Gower
ingdom. Tel.: þ44 020 7679 1735.
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C. Vrinten, J. Wardle / European Journal of Cancer 56 (2016) 172e178 173Conclusion: Despite the media commotion, a surprisingly high proportion of middle-aged and
older adults viewed cancer as ‘the best way to die’ and rated cancer death as better than heart
disease. Given that one in two of us are likely to be diagnosed with cancer, conversations
about a good death from cancer may in a small way mitigate fear of cancer. Future research
could explore variations by type of cancer or heart disease and by previous experience of these
illnesses in others.
ª 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC
BY license (http://creativecommons.org/licenses/by/4.0/).‘Your death, near now, is of an easy sort. So slow a fading out
brings no real pain’ Clive James (2014).
1. Background
Despite improved outcomes over recent decades, cancer
remains widely feared, and is frequently seen as synony-
mous with ‘a death sentence’ [1]. Worse still, cancer death
is often portrayed as protracted and painful: ‘[Cancer is]
a really unpleasant way to go . I wouldn’t wish it on
anyone’ [2], or ‘[There are] much better way[s] to go than
lying in a bed for 6 months dying of cancer’ [2]. Fear of
cancer death may partly have inspired the so-called ‘war
on cancer’ [3], in an effort to reduce the burden of
suffering and mortality associated with this disease.
Cancer accounts for nearly a third of all deaths in the
UnitedKingdom (UK) each year [4]. Heart disease claims
about the same number of lives every year [4], but public
perceptions of what it is like to die from these two diseases
are vastly different. Dying from cancer tends to be seen as
‘painful’, ‘dragging on’ and causing extreme suffering,
while dying from heart disease is seen as ‘quick and neat’,
‘natural’, and ‘relatively painless’ [2,5]. These public
perceptions influence the dread associated with each dis-
ease [2], people’s willingness to engage in health behav-
iour change to prevent them [2,5], and research funding
allocation [6]. In her classic work ‘Illness as Metaphor’,
Susan Sontag states that ‘cancer is more feared than heart
disease [.] if only because it [i.e. heart disease] can be
instantaneous, an easy death’ [7]. In popular opinion,
heart disease seems to be ‘the more desirable’ way to go,
because of its association with a sudden death [2,8].
A strikingly contrasting view was expressed by the
former editor-in-chief of the BMJ, Dr. Richard Smith,
when he argued in a BMJ blog post that cancer is ‘the
best way to die’, because it allows you to ‘say goodbye,
reflect on your life, leave last messages, perhaps visit
special places for a last time, listen to favourite pieces of
music, read loved poems, and prepare, according to your
beliefs, to meet your maker or enjoy eternal oblivion’ [8].
His blog post attracted much criticism on Internet fo-
rums [8,9], as well as in the UK’s national media
[10e12]. Smith’s views were called ‘insensitive’,
‘misguided’, and ‘highly offensive’ to cancer patients and
their families [10]. Many countered his views by relating
stories of people who had died a horrible death fromcancer. But is his really such an idiosyncratic view? In
the public’s mind, are cancer deaths synonymous with
‘bad deaths’?
What constitutes a good death has been well
researched, and various common characteristics of ‘a
good death’ have been reported across studies [13e15].
Examples of these include being in control over what
happens, being comfortable (i.e. adequate control of
pain and other symptoms), and being afforded dignity
and privacy [14,16,17]. Most of these studies examine
the characteristics of a good death according to patients
with a terminal illness, their caregivers, the recently
bereaved, or end-of-life healthcare professionals, such as
hospice staff. To our knowledge, it is unknown whether
the same characteristics are considered important by the
general population. In this study, we examined how
middle-aged and older adults rated death from cancer
and death from heart disease, the two most common
types of adult mortality [4], on measures of a good
death, to obtain a better understanding of lay percep-
tions of dying from cancer and to explore whether death
from cancer is really perceived as negatively as suggested
by the media responses to Smith’s blog.
2. Methods
This study was part of an online survey on attitudes and
beliefs about cancer that we carried out in February
2015 in a UK population sample of 50- to 70-year olds
(nZ 391), using a commercial sampling service. Quotas
were set for gender and education to create equal groups
across their categories. Informed consent to participate
was obtained at the start of the survey. The study was
exempt from ethics approval.
We selected five characteristics of a good death from
the end-of-life literature: [13,14] having control over
what happens such as who is present or whether one dies
at home or in hospital, having control over pain relief
and other symptoms, having the opportunity to settle
affairs, having time to say goodbye to loved ones, and
being able to live independently and with dignity until
death. We asked respondents to estimate the likelihood
of each characteristic (four-point scales labelled from 1
‘extremely unlikely’ to 4 ‘extremely likely’) for death
from cancer and death from heart disease. A ‘don’t
know’ response option was also provided for these
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each characteristic for their own death (four-point scale
from 1 ‘not at all important’ to 4 ‘extremely important’;
a ‘prefer not to say’ option was also provided). Finally,
we quoted Smith’s argument about cancer being the
‘best way to die’ verbatim [8], and asked respondents
whether they agreed with him (‘strongly disagree’, ‘tend
to disagree’, ‘tend to agree’, ‘strongly agree’).
Demographic data included gender, education,
ethnicity, age, and diagnosis of cancer (excluding non-
melanoma skin cancer) and heart disease, which were
assessed with simple questions. Age was dichotomised to
create younger and older groups (‘50e60’ versus
‘61e70’). Education was classified into three levels:
‘finished education at or before age 15’, ‘completed
CSEs or O-levels’, and ‘finished A-levels or higher ed-
ucation’. The ethnicity question had the following
response options: ‘White’, ‘Black’, ‘Asian’, ‘other’, and
‘prefer not to say’. ‘Prefer not to say’ and ‘don’t know’
responses were coded as missing throughout.
To assess the validity of our choice of characteristics
of ‘a good death’, we looked at the response distribu-
tions of the importance of each characteristic for re-
spondents’ own death. We calculated mean scores for
the likelihood of each characteristic, as well as across all
five items, for death from cancer and heart disease. We
used t-tests to examine differences between the scores for
cancer and heart disease, both for the combined measure
and for individual items. Finally, we determined the
percentage agreement with Smith’s statement and
examined associations between agreement and ratings of
the likelihood of the good death characteristics for
cancer. Associations with demographic variables were
examined using analyses of variance and chi-square tests
as appropriate. When associations with demographic
variables were found, these were adjusted for in subse-
quent analyses. All analyses were done using SPSS v22,
and a p-value of <0.05 was defined as threshold for
statistical significance.
There are two important points that we decided not
to address in this study. Firstly, evidence from the pre-
vious studies suggests that public perceptions of cancer
vary across different types of cancer, according to their
perceived survivability, stigma, visibility, and other
characteristics [18,19]. The same may be true for
different types of heart disease. In the present study, we
did not distinguish between different types of cancer or
heart disease because we were interested in the com-
parison of generic lay perceptions of ‘cancer’ versus
‘heart disease’. Previous research suggests that these lay
perceptions are very different, regardless of the vari-
ability within each disease group [2].
Secondly, perceptions of what it would be like to die
from a particular disease may be shaped by past expe-
riences of others dying from that disease. However, given
that most people have experiences of cancer in others [20]
and the high prevalence of cancer and heart diseasedeaths in the general population, it may be the quality of
the past experience (what kind of death someone died,
rather than just the experience that someone died) that is
important in how illness experience affects illness per-
ceptions. To our knowledge, there are no validated
measures for the quality of past illness experiences in
others, and for this reason, we decided not to include
measures of illness experience in our survey.3. Results
The mean age of our sample was 60.4 years (SDZ 6.0).
The majority of respondents (98%) were from a White
ethnic background; so, differences by ethnicity were not
explored further. Consistent with the sampling quotas
applied for gender and education, approximately half
(52%) the sample were female and 34% had finished
school at or before 15 years, while 34% had A levels or
higher education (Table 1). Thirty-six respondents
(9.2%) were diagnosed with heart disease, and 33 (8.4%)
with cancer. Excluding these participants did not change
the direction of the results; so, the analyses for the
bigger sample are presented below.
Fig. 1 shows respondents’ ratings of the importance
of each characteristic of ‘a good death’ for their own
death. At least 95% of respondents agreed that these
characteristics would be important, with mean ratings
for each characteristic between ‘quite’ and ‘extremely’
important. The response distributions were similar
across items, except for ‘having control over what hap-
pens when you die’, which fewer respondents rated as
‘extremely important’ than the other four characteristics
(Fig. 1). There were slight differences by gender and
education, but not age (see Table 1); so, we adjusted for
demographic variables in the subsequent series of mul-
tiple linear regression models run for each characteristic
individually (Table 2). These revealed that, on average,
scores for women were slightly higher than for men on
all but one characteristic, and those with higher levels of
education attached slightly more importance to having
control over symptoms and having time to settle affairs
(Tables 1 and 2). No demographic differences were
found for the other characteristics.
Comparing the average likelihood ratings for cancer
and heart disease across all five characteristics, we found
that the average score was significantly more positive for
cancer than heart disease death (3.1 versus 2.9, tZ 5.02,
p < 0.0001), with no demographic differences for either
outcome (results not shown). On an individual item
basis, death from cancer was seen as significantly more
likely to provide control over what happens (3.0 versus
2.8, t Z 5.01, p < 0.001), control over pain and other
symptoms (3.0 versus 2.9, t Z 2.84, p  0.01), time to
settle affairs (3.3 versus 3.1, t Z 3.95, p < 0.001), and
time to say goodbye to loved ones (3.3 versus 3.1,
t Z 5.01, p < 0.001, see also Fig. 2). There were no
Table 1
Sample characteristics and the means and SDs of importance of each characteristic of ‘a good death’ for respondents’ own death, scored on a



















60 or younger 188 (49.5) 3.49 (0.74) 3.75 (0.52) 3.64 (0.63) 3.74 (0.57) 3.69 (0.56)
Older than 60 192 (50.5) 3.42 (0.69) 3.68 (0.50) 3.67 (0.52) 3.68 (0.56) 3.68 (0.56)
Gender
Male 183 (48.2) 3.32 (0.79) 3.65 (0.56) 3.58 (0.64) 3.63 (0.65) 3.64 (0.58)
Female 197 (51.8) 3.58 (0.61) 3.77 (0.46) 3.73 (0.51) 3.79 (0.47) 3.73 (0.54)
Education
Finished school 15 years 129 (33.9) 3.38 (0.73) 3.64 (0.60) 3.54 (0.70) 3.67 (0.64) 3.60 (0.65)
CSEs or O-levels 122 (32.1) 3.46 (0.74) 3.69 (0.50) 3.67 (0.55) 3.72 (0.55) 3.72 (0.47)
A levels or higher 129 (33.9) 3.53 (0.67) 3.81 (0.42) 3.76 (0.45) 3.74 (0.50) 3.74 (0.52)
Abbreviations: CSE, certificate of secondary education; SD, standard deviation.
Fig. 1. Respondents’ ratings of importance of each characteristic of ‘a good death’ for their own death (N Z 391).
Table 2
Multiple linear regression analyses of predictors of importance of each characteristic of ‘a good death’ for respondents’ own death, adjusted for











B (SE B) b B (SE B) b B (SE B) b B (SE B) b B (SE B) b
Age (years)
>60 versus 60 0.04 (0.08) 0.03 0.05 (0.05) 0.05 0.07 (0.06) 0.06 0.05 (0.06) 0.04 0.02 (0.06) 0.02
Gender
Female versus male 0.26 (0.07) 0.18 0.12 (0.05) 0.12 0.14 (0.06) 0.12 0.16 (0.06) 0.14 0.09 (0.06) 0.08
Education
CSEs or O levels versus not 0.06 (0.09) 0.04 0.03 (0.07) 0.02 0.15 (0.07) 0.12 0.04 (0.07) 0.03 0.12 (0.07) 0.10
A levels or higher versus not 0.15 (0.09) 0.10 0.15 (0.06) 0.14 0.23 (0.07) 0.19 0.07 (0.07) 0.06 0.14 (0.07) 0.12
Constant 3.28 (0.09) 3.62 (0.06) 3.42 (0.07) 3.62 (0.07) 3.54 (0.07)
Adjusted R2 (model) 0.032 0.025 0.032 0.014 0.008
Abbreviations: CSE, certificate of secondary education; B Z unstandardised regression coefficient; SE Z standard error; b Z standardised
regression coefficient.
Note: Values in bold are statistically significant at p < .05.
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death (p > .05).
When respondents were asked directly whether they
agreed with Smith that cancer was ‘the best way to die’,
40% agreed (34% ‘tend to agree’, 6% ‘strongly agree’),
while 60% disagreed (32% ‘tend to disagree’, 28%
‘strongly disagree’). Chi-square tests showed no signifi-
cant demographic differences (results not shown).Respondents who rated cancer death as having rela-
tively more positive features were slightly, but not
significantly, more likely to agree (r Z 0.09, p Z 0.08).
4. Discussion
To our knowledge, this is the first study that examined
how middle-aged and older adults rate dying from
Fig. 2. Perceived likelihood of each characteristic of ‘a good death’ for death from cancer (CA) and heart disease (HD); dichotomised for
ease of interpretation into ‘likely or very likely’ vs ‘unlikely or very unlikely’. Note: *p < .01, **p < .001.
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compared these with lay perceptions of dying from heart
disease. Contrary to popular belief or the responses to
Smith’s blog, middle-aged and older adults rated death
from cancer slightly more positively than death from
heart disease on five parameters of ‘a good death’. We
also found that a substantial proportion (40%) of survey
respondents agreed with Smith’s argument that cancer
could be ‘the best way to die’.
The finding that cancer death was viewed more
positively than heart disease death is reflected in
studies of quality of care. The National Survey of
Bereaved People records bereaved people’s views on
the quality of care provided to a friend or relative in
the last three months of life in England [21]. This
annual survey has shown that over the period
2011e2013, quality of care for those who died from
cancer was more often rated as ‘outstanding’ or
‘excellent’ (51%) than death from cardiovascular dis-
ease (37e40%) or other causes (40e41%) [21]. Studies
about the needs and use of palliative care by cancer
and cardiac patients have shown that cardiac patients
are less likely than cancer patients to be entered on the
palliative care register [22] and that they receive fewer
health, social, and palliative care services [23].
The relatively more negative tone about death from
cancer in the responses to Smith’s blog than seen in our
survey could be explained partly by a ‘strength of feeling’
effect. It is well-known in online product marketing
research that people with more extreme views (either
satisfied or dissatisfied) are more likely to leave a product
review [24]. A similar self-selection may have been at
work for the blog respondents, resulting in over-
representation of the views of those who disagreed. The
current survey may suffer less from this strength of
feeling effect (since respondents did not know in advance
which questions they would be asked in the survey) and
may thus form a better indication of lay perceptions of
dying from cancer than the blog responses.The debate about what constitutes a good death, and
whether cancer could fit the bill, is an important one. In
a world where one in two of us are likely to be diagnosed
with cancer [25], of whom many will die of e or with e
cancer, it is encouraging that people are able to consider
that a cancer death can be ‘a good death’. It was also
interesting to see the consensus on what people valued
for their own death; we may have little choice over our
ultimate cause of death, but we may have some control
over how we die, as reflected in increasing interest in
advanced directives and care planning [26,27].
However, plans for end-of-life care may still not al-
ways be clearly communicated. A recent survey found
that 83% of Britons believe that people in Britain feel
uncomfortable discussing death and dying, and 51% do
not know the end-of-life wishes of their partner [28].
Preferences for end-of-life care may also not always be
acted upon: over half of Britons (59%) said they would
not know how to arrange end-of-life care for themselves
or a family member [28], and although 70e80% prefer to
die at home, nearly half of all deaths in England occur in
hospitals [21,28]. These statistics show that much re-
mains to be done to ensure that a good death becomes a
standard of care for the dying. The Cancer Taskforce’s
ambition to increase the number of terminal cancer
patients who experience ‘a good death’ [29] and the
‘national choice offer’ [30] aspire to open up dialogues
between patients and carers about quality of care at the
end of life. Future studies will need to assess whether
these proposals are effective.
This study has several limitations. In the sampling,
quotas were set for education level and gender, but
weighting or propensity scoring were deemed inappro-
priate for such a small sample size, and this means that the
sample may not have been representative of the middle-
aged and older UK population. Population representa-
tiveness may have been further attenuated by the recruit-
ment method. For example, previous research has found a
protective effect of Internet use on health literacy decline in
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health-literate sample compared with the general popula-
tion [31]. The current study would need to be replicated in
population-representative samples. Future studies would
alsobeneeded todeterminewhether the results of this study
are generalisable beyond the UK setting. For example,
attitudes towards dying from cancer may be different in
countries with less well-developed palliative care systems.
Furthermore, only two causes of deathwere compared; so,
we cannot comment on people’s views about what would
be ‘the best way to die’ across all causes of death, although
we note that 40% of our sample agreed with Smith that
cancer would be the best way to go. Although our results
show that middle-aged and older adults do seem to be able
to consider that there are some benefits to a cancer death,
this may also be true for other conditions that have the
characteristics that people valued in a cancer death.
Furthermore, as explained before, perceptions of dying
fromcanceror heartdiseasemayvaryacrossdifferent types
of cancer or heart disease, and future studies could explore
their influence. In addition, this study did not address the
origins of people’s attitudes towards dying from cancer
versus heart disease, which may be influenced by factors
such as previous experience with the illness in others as
explained in the Methods section. Future studies could
explore the origins of the differences in attitudes that were
found in this study. We found statistical differences in the
likelihood of dying a good death from cancer or heart
disease, but further researchwouldneed to explorewhether
these differences are meaningful in an everyday setting. To
our knowledge, no validated scales exist to measure the
general public’s views about a good death, and the current
study could be used to inform future studies addressing this
issue. We only used five characteristics of a ‘good death’,
and although respondents indicated that these were indeed
important, theremay be other features of a good death that
could be important to include in future research, such as
preferences for quickness of dying [14]. The question about
cancer being ‘the best way to die’ was asked after re-
spondents had rated the likelihood of each death charac-
teristic for heart disease and cancer, which may have
resulted inhigher rates of agreemente anunintendedeffect
of theorder inwhich thequestionswereasked in the survey.
We believe, however, that the reverse order of the items
could have resulted in a greater response bias due to
inherent preferences to avoid cognitive dissonance, i.e. a
respondent couldhave ratedcharacteristics of a gooddeath
for cancer systematically as more unlikely after first dis-
agreeingwith the statement that cancer is a goodway to die
in order to provide consistent answers. Futurework should
vary presentation order.
5. Conclusion
In conclusion, media responses to Smith’s blog post
indicated that almost no one shared his views, but our
results suggest he is not alone in considering thepossibility that cancer is ‘a good way to die’. His blog
was regarded as insensitive, but there may be no easy
way to raise the topic. Perhaps, he has initiated a con-
versation that will help all of us e including those with
cancer e to consider the end game. Conversations like
this one may help allay fear of dying in general and fear
of dying of cancer in particular.
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